Allogene: Continuing To Deliver Solid Data In Allogeneic CART
koto_feja/E+ via Getty Images
Allogene (ALLO) is a developer of next generation CAR-T therapies for heme and solid tumors. Despite its high valuation, Allogene is very early stage – that is its essential problem. However, Allogene is a leader in a cutting…
